Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept
暂无分享,去创建一个
[1] W. Solass,et al. Description of a novel approach for intraperitoneal drug delivery and the related device , 2011, Surgical Endoscopy.
[2] F. Roviello,et al. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. , 2011, Surgical oncology.
[3] N. Zaffaroni,et al. Pathophysiology and biology of peritoneal carcinomatosis. , 2010, World journal of gastrointestinal oncology.
[4] M. Deraco,et al. Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. , 2010, World journal of gastrointestinal oncology.
[5] M. Dutreix,et al. Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage Response , 2009, PloS one.
[6] Jean-Luc Coll,et al. Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy , 2009, Clinical Cancer Research.
[7] P. Morel,et al. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator , 2009, Surgical Endoscopy.
[8] Thomas Helleday,et al. DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.
[9] J. Guy,et al. Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy , 1995, Molecular biotechnology.